164 related articles for article (PubMed ID: 7699678)
1. Pharmacokinetics and renal function in patients with rheumatoid arthritis receiving a standard dose of oral weekly methotrexate: association with significant decreases in creatinine clearance and renal clearance of the drug after 6 months of therapy.
Kremer JM; Petrillo GF; Hamilton RA
J Rheumatol; 1995 Jan; 22(1):38-40. PubMed ID: 7699678
[TBL] [Abstract][Full Text] [Related]
2. Examination of pharmacokinetic variables in a cohort of patients with rheumatoid arthritis beginning therapy with methotrexate compared with a cohort receiving the drug for a mean of 81 months.
Kremer JM; Petrillo GF; Hamilton RA
J Rheumatol; 1995 Jan; 22(1):41-4. PubMed ID: 7699679
[TBL] [Abstract][Full Text] [Related]
3. The effects of nonsteroidal antiinflammatory drugs on methotrexate (MTX) pharmacokinetics: impairment of renal clearance of MTX at weekly maintenance doses but not at 7.5 mg.
Kremer JM; Hamilton RA
J Rheumatol; 1995 Nov; 22(11):2072-7. PubMed ID: 8596147
[TBL] [Abstract][Full Text] [Related]
4. The effects of food on methotrexate absorption.
Hamilton RA; Kremer JM
J Rheumatol; 1995 Apr; 22(4):630-2. PubMed ID: 7791153
[TBL] [Abstract][Full Text] [Related]
5. Methotrexate kinetics in rheumatoid arthritis: is there an interaction with nonsteroidal antiinflammatory drugs?
Ahern M; Booth J; Loxton A; McCarthy P; Meffin P; Kevat S
J Rheumatol; 1988 Sep; 15(9):1356-60. PubMed ID: 3199396
[TBL] [Abstract][Full Text] [Related]
6. Lack of correlation between pharmacokinetics and efficacy of low dose methotrexate in patients with rheumatoid arthritis.
Lafforgue P; Monjanel-Mouterde S; Durand A; Catalin J; Acquaviva PC
J Rheumatol; 1995 May; 22(5):844-9. PubMed ID: 8587070
[TBL] [Abstract][Full Text] [Related]
7. Combination therapy with methotrexate and hydroxychloroquine for rheumatoid arthritis increases exposure to methotrexate.
Carmichael SJ; Beal J; Day RO; Tett SE
J Rheumatol; 2002 Oct; 29(10):2077-83. PubMed ID: 12375315
[TBL] [Abstract][Full Text] [Related]
8. Lack of interaction between bromfenac and methotrexate in patients with rheumatoid arthritis.
Gumbhir-Shah K; Cevallos WH; DeCleene SA; Korth-Bradley JM
J Rheumatol; 1996 Jun; 23(6):984-9. PubMed ID: 8782127
[TBL] [Abstract][Full Text] [Related]
9. Combined oral cyclosporin and methotrexate therapy in patients with rheumatoid arthritis elevates methotrexate levels and reduces 7-hydroxymethotrexate levels when compared with methotrexate alone.
Fox RI; Morgan SL; Smith HT; Robbins BA; Choc MG; Baggott JE
Rheumatology (Oxford); 2003 Aug; 42(8):989-94. PubMed ID: 12730515
[TBL] [Abstract][Full Text] [Related]
10. A pilot study of pharmacokinetically guided dosing of oral methotrexate in the initial phase of psoriasis treatment.
Hroch M; Chladek J; Simkova M; Vaneckova J; Grim J; Martinkova J
J Eur Acad Dermatol Venereol; 2008 Jan; 22(1):19-24. PubMed ID: 18031504
[TBL] [Abstract][Full Text] [Related]
11. Is there an interaction between low doses of corticosteroids and methotrexate in patients with rheumatoid arthritis? A pharmacokinetic study in 33 patients.
Lafforgue P; Monjanel-Mouterde S; Durand A; Catalin J; Acquaviva PC
J Rheumatol; 1993 Feb; 20(2):263-7. PubMed ID: 8474062
[TBL] [Abstract][Full Text] [Related]
12. Splitting high-dose oral methotrexate improves bioavailability: a pharmacokinetic study in patients with rheumatoid arthritis.
Hoekstra M; Haagsma C; Neef C; Proost J; Knuif A; van de Laar M
J Rheumatol; 2006 Mar; 33(3):481-5. PubMed ID: 16463431
[TBL] [Abstract][Full Text] [Related]
13. Determinants of red blood cell methotrexate polyglutamate concentrations in rheumatoid arthritis patients receiving long-term methotrexate treatment.
Stamp LK; O'Donnell JL; Chapman PT; Zhang M; Frampton C; James J; Barclay ML
Arthritis Rheum; 2009 Aug; 60(8):2248-56. PubMed ID: 19644853
[TBL] [Abstract][Full Text] [Related]
14. High-dose methotrexate therapy of childhood acute lymphoblastic leukemia: lack of relation between serum methotrexate concentration and creatinine clearance.
Joannon P; Oviedo I; Campbell M; Tordecilla J
Pediatr Blood Cancer; 2004 Jul; 43(1):17-22. PubMed ID: 15170885
[TBL] [Abstract][Full Text] [Related]
15. Lack of significant interaction between low dose methotrexate and ibuprofen or flurbiprofen in patients with arthritis.
Skeith KJ; Russell AS; Jamali F; Coates J; Friedman H
J Rheumatol; 1990 Aug; 17(8):1008-10. PubMed ID: 2213774
[TBL] [Abstract][Full Text] [Related]
16. Patients with rheumatoid arthritis treated with methotrexate (MTX): concentrations of steady-state erythrocyte MTX correlate to plasma concentrations and clinical efficacy.
Hornung N; Ellingsen T; Attermann J; Stengaard-Pedersen K; Poulsen JH
J Rheumatol; 2008 Sep; 35(9):1709-15. PubMed ID: 18634162
[TBL] [Abstract][Full Text] [Related]
17. Methotrexate-nonsteroidal antiinflammatory drug interaction in children with arthritis.
Dupuis LL; Koren G; Shore A; Silverman ED; Laxer RM
J Rheumatol; 1990 Nov; 17(11):1469-73. PubMed ID: 2273487
[TBL] [Abstract][Full Text] [Related]
18. Bioavailability of higher dose methotrexate comparing oral and subcutaneous administration in patients with rheumatoid arthritis.
Hoekstra M; Haagsma C; Neef C; Proost J; Knuif A; van de Laar M
J Rheumatol; 2004 Apr; 31(4):645-8. PubMed ID: 15088287
[TBL] [Abstract][Full Text] [Related]
19. Celecoxib, a specific COX-2 inhibitor, has no significant effect on methotrexate pharmacokinetics in patients with rheumatoid arthritis.
Karim A; Tolbert DS; Hunt TL; Hubbard RC; Harper KM; Geis GS
J Rheumatol; 1999 Dec; 26(12):2539-43. PubMed ID: 10606360
[TBL] [Abstract][Full Text] [Related]
20. Bayesian calculation of methotrexate clearance after low dose intramuscular administration in patients with rheumatoid arthritis.
Monjanel-Mouterde S; Lafforgue P; Blanc A; Catalin J; Aquaviva PC; Durand A
J Rheumatol; 1998 Jul; 25(7):1276-81. PubMed ID: 9676756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
